The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Biotech veteran Tony Coles explains how he navigates partisan politics — and how he is seeking to fulfill a promise to a late colleague. #STATSummit ...

As life expectancies increase, "we're going to spend half our lives in the care of needing assistance along the way,” says Atul Gawande.

On Thursday, Elevance Health disclosed in its third quarter earnings release that its medical loss ratio — the amount of ...

Alnylam's Yvonne Greenstreet, at #STATSummit, predicts vutrisiran will become multibillion-dollar product for ...

Micky Tripathi, a top HHS official, said the election won’t impact AI regulations, despite fears that a Trump administration ...

The doctors said they lost control over their schedules, were told to prioritize coding patients’ illnesses, and felt like ...

Because of race-based estimates, thousands of Black patients were placed further down kidney transplant waitlists.

Today's health news includes highlights from the STAT Summit, a new option for people with HIV who need kidneys, and GLP-1s ...

STAT’s Matthew Herper picked Bristol Myers Squibb CEO Chris Boerner’s brain at the STAT Summit on all things related to the ...